Show simple item record

dc.contributor.authorVilariño-García, Teresa
dc.contributor.authorPolonio González, María L.
dc.contributor.authorPérez Pérez, Antonio
dc.contributor.authorRibalta, Josep
dc.contributor.authorArrieta, Francisco
dc.contributor.authorAguilar Diosdado, Manuel 
dc.contributor.authorObaya, Juan C.
dc.contributor.authorGimeno Orna, José A.
dc.contributor.authorIglesias, Pedro
dc.contributor.authorNavarro, Jorge
dc.contributor.authorDurán, Santiago
dc.contributor.authorPedro-Botet, Juan
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2024-06-20T13:06:19Z
dc.date.available2024-06-20T13:06:19Z
dc.date.issued2024
dc.identifier.issn1422-0067
dc.identifier.issn1661-6596
dc.identifier.urihttp://hdl.handle.net/10498/32682
dc.description.abstractDiabetes mellitus (DM) is a highly prevalent disease worldwide, estimated to affect 1 in every 11 adults; among them, 90–95% of cases are type 2 diabetes mellitus. This is partly attributed to the surge in the prevalence of obesity, which has reached epidemic proportions since 2008. In these patients, cardiovascular (CV) risk stands as the primary cause of morbidity and mortality, placing a substantial burden on healthcare systems due to the potential for macrovascular and microvascular complications. In this context, leptin, an adipocyte-derived hormone, plays a fundamental role. This hormone is essential for regulating the cellular metabolism and energy balance, controlling inflammatory responses, and maintaining CV system homeostasis. Thus, leptin resistance not only contributes to weight gain but may also lead to increased cardiac inflammation, greater fibrosis, hypertension, and impairment of the cardiac metabolism. Understanding the relationship between leptin resistance and CV risk in obese individuals with type 2 DM (T2DM) could improve the management and prevention of this complication. Therefore, in this narrative review, we will discuss the evidence linking leptin with the presence, severity, and/or prognosis of obesity and T2DM regarding CV disease, aiming to shed light on the potential implications for better management and preventive strategieses_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceInternational Journal of Molecular Sciences, Vol. 25, Núm. 4, 2024es_ES
dc.subjectcardiovascular riskes_ES
dc.subjectinflammationes_ES
dc.subjectleptines_ES
dc.subjectobesityes_ES
dc.subjecttype 2 diabetes mellituses_ES
dc.titleRole of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabeteses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/IJMS25042338
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucía//CTS-151/ES/Bioquimica Medica/ es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional